|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
|
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Deferred offering costs | |||||||
| Current assets: | |||||||
| Cash | |||||||
| Prepaid insurance - current | |||||||
| Prepaid expenses | |||||||
| Cash and cash equivalents | |||||||
| Receivables under collaboration agreements (includes $0 and $1,000 as related party as of June 30, 2026, and December 31, 2025, respectively) | |||||||
| Inventory | |||||||
| Deferred transaction costs | |||||||
| Prepaid expenses and other current assets (includes $720 and $1,110 as related party as of June 30, 2026, and December 31, 2025, respectively) | |||||||
| Total current assets | |||||||
| Prepaid insurance - long term | |||||||
| Investments held in Trust Account | |||||||
| Restricted cash | |||||||
| Property and equipment, net | |||||||
| Operating lease right-of-use assets, net | |||||||
| Other non-current assets | |||||||
| Related Party | |||||||
| Nonrelated Party | |||||||
| Total other non-current assets | |||||||
| Total Assets | |||||||
| Liabilities, Redeemable Convertible Preferred Stock & Stockholders’ Equity (Deficit) | |||||||
| Current liabilities: | |||||||
| Accrued offering costs | |||||||
| Accounts payable (includes $0 and $190 as related party, as of September 30, 2026, and December 31, 2025, respectively) | |||||||
| Accrued expenses | |||||||
| Promissory note - related party | |||||||
| Deferred revenue | |||||||
| Operating lease liabilities, current portion | |||||||
| Total current liabilities | |||||||
| Deferred underwriting fee | |||||||
| Operating lease liabilities, net of current portion | |||||||
| Convertible promissory notes – related parties, at fair value | |||||||
| Warrant liabilities | |||||||
| Series B-1 and Series D redeemable convertible preferred stock warrants | |||||||
| Warrants for Series A | |||||||
| Total liabilities | |||||||
| Redeemable convertible preferred stock | |||||||
| Series A-1 redeemable convertible preferred stock | |||||||
| Series A-2 redeemable convertible preferred stock | |||||||
| Series B-1 redeemable convertible preferred stock | |||||||
| Series C-1 redeemable convertible preferred stock | |||||||
| Series C-2 redeemable convertible preferred stock | |||||||
| Series D redeemable convertible preferred stock | |||||||
| Redeemable Class A | |||||||
| Total series D redeemable convertible preferred stock | |||||||
| Total redeemable convertible preferred stock | |||||||
| Stockholders’ equity (deficit): | |||||||
| Preferred stock, $0.00001 pare value, 100,000,000 authorized as of June 30, 2026. No shares were authorized as of December 31, 2025. | |||||||
| Common stock | |||||||
| Series A Common stock | |||||||
| Series B Common stock | |||||||
| Additional paid-in capital | |||||||
| Accumulated deficit | |||||||
| Accumulated other comprehensive income (loss) | |||||||
| Total stockholders’ equity (deficit) | |||||||
| Total Liabilities, Redeemable Convertible Preferred Stock & Stockholders’ Equity (Deficit) | |||||||
| Common stock, par value (in usd per share) |
Loading...